This JAMA Insights Clinical Update reviews indications for use of medications for primary prevention of breast cancer and the comparative effectiveness and adverse effects of selective estrogen receptor modulators (tamoxifen, raloxifene) and aromatase inhibitors (anastrozole, exemestane) for this purpose.